Fasciculation
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Median Effective Dose of Cisatracurium for the Prevention of Fasciculation Caused by the Injection of Succinylcholine (NCT05760976) | Yangzhou University | 2023-02-01 |
| Study to Evaluate Safety & Efficacy of FLX-787-ODT to Treat Fasciculations in Tongue and Appendicular Muscle in Adult Subjects With ALS (NCT03334786) | Flex Pharma, Inc. | 2018-04-05 |
| Study to Evaluate the Safety & Efficacy of FLX-787-ODT to Treat Fasciculations in Tongue and Upper or Lower Extremity Muscles Most Affected in Subjects With ALS (NCT03338114) | Flex Pharma, Inc. | 2017-11-01 |
| Effects of Cisatracurium on Succinylcholine-induced Fasciculations and Myalgia (NCT02481193) | Yangzhou No.1 People's Hospital | 2013-03-01 |
Track Fasciculation automatically
Every clearance here is in the API, with alerts when new ones post.